Remedent, Inc. (REMI)
OTCMKTS · Delayed Price · Currency is USD
0.0008
+0.0001 (14.29%)
At close: Sep 9, 2026
Remedent Revenue
In the fiscal year ending March 31, 2023, Remedent had annual revenue of 46.11K EUR, down -88.53%. Remedent had revenue of -459.56K in the quarter ending March 31, 2021. That makes Remedent the 46,514th largest company in the world by revenue and 6,936th in the United States.
Revenue
46.11K EUR
Revenue Growth
-94.86%
P/S Ratio
0.31
Revenue / Employee
15.37K EUR
Employees
3
Market Cap
15.42K USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2023 | 46.11K | -355.79K | -88.53% |
| Mar 31, 2022 | 401.91K | 112.97K | 39.10% |
| Mar 31, 2021 | 288.94K | 68.77K | 31.23% |
| Mar 31, 2020 | 220.17K | -1.21M | -84.59% |
| Mar 31, 2019 | 1.43M | -762.54K | -34.80% |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| InnerScope Hearing Technologies | 14.51M |
| Medite Cancer Diagnostics | 8.13M |
| SheerVision | 2.84M |
| BG Medicine | 1.57M |
| Paradigm Medical Industries | 757.00K |
| Wearable Health Solutions | 600.26K |
| Medical International Technology | 397.69K |
| Hear AtLast Holdings | 93.20K |
Remedent News
- 5 years ago - Remedent, Inc. Files Form 15 to Suspend SEC Exchange Act Registration and Applies to Qualify for OTC Markets Alternative Reporting Standard for Pink Sheet Companies - GlobeNewsWire